NantKwest

Investments

2

Lead Investments

1

NantKwest is a pioneering, next-generation, clinical-stage immunotherapy company focused on harnessing the unique power of the immune system to treat diseases, particularly cancer. It is now part of ImmunityBio, Inc., which continues to develop innovative immunotherapy treatments.

Founded 2002

North America, United States

51-100

immunitybio.com